1. Home
  2. Live Updates
  3. Immunology research

Page 34 - Immunology Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immunology research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immunology Research Today - Breaking & Trending Today

SARS-CoV-2 Infection May Mean Need For A CD8+ T Cell Response Booster

A recent study found that vaccination with two doses of the Pfizer-BioNTech COVID-19 vaccine resulted in immune cell response considerably lower in people with prior SARS-CoV-2 infection than those without. ....

Ask Dr. Universe; The many parts of an immune system

Dear Dr. Universe ....

United States , Phil Mixter , Washington State University , Washington State , Armed Forces ,

Biomarkers for Treatment Response Evaluated in Children With CSU

The results add to current understanding of the role of different biomarkers in treatment response, in this population, according to the lead study author. ....

Northwestern University , United States , Raj Chovatiya , Alex Nguyen , American Academy Of Dermatology , Mcgill University , American Academy , Montreal Children , Hospital Allergy , Immunology Clinic , Iological Marker , Platelet Count , Latelet Count Plt , Hrombocyte Count , Osinophil Granulocytes , Biologic Therapy , Thyroid Disorder ,

Youth Health and Leadership Conference set for March 20 in Tahlequah

In observance of National Native HIV/AIDS Awareness Day, the Cherokee County Health Services Council will be hosting high school students for a Youth Health and Leadership Conference on March 20. ....

United States , Cherokee County , Paul Martinez , Cherokee County Health Services Council , Northeastern State University Ballroom In Tahlequah , National Native , Youth Health , Leadership Conference , Northeastern State University Ballroom , Oklahoma Interlocal Cooperation Act , Project Director Paul Martinez ,

FDA to Review Dupilumab for Chronic Spontaneous Urticaria

The application for FDA approval for CSU is based on data from a pair of phase 3 trials in two different populations. ....

United States , Dupilumab Dupixent , Drug Administration , American Academy Of Allergy , Biologics License Application , Biologic Therapy , Anti Immunoglobulin E , Nti Ige , Adolescent Medicine , Fairway Management , Anagement Airway , Angioneurotic Edema , Atopic Dermatitis , Monoclonal Antibody ,